Fluoride ion F-18 Terminated Phase 1 Trials for Metastatic Malignant Neoplasm in the Bone / metastatic Carcinoma of the Prostate / Hormone Resistant Prostate Cancer Diagnostic

IndicationsStatusPurposePhase
TerminatedDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT02429804NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer